Dimethylamine

Dimethylamine

SCHEMBL2159697

C[NH2+]C.F[B-](F)(F)F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL17871158 0.82
Butane SCHEMBL2158974 0.82
Fluoromethane SCHEMBL28011400 0.72
Ethane SCHEMBL18837989 0.72
Ethane SCHEMBL5590416 0.72
SCHEMBL16047646 0.71
SCHEMBL7107352 0.71
SCHEMBL63026 0.71
SCHEMBL63222 0.71
SCHEMBL6216 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109170-A1 METHOD FOR MANUFACTURING GANIRELIX ANYGEN CO., LTD. (KR) 2025-04-03 US claimed
CN-116848092-A Process for preparing pyrimidine cyclohexyl glucocorticoid receptor modulators 科赛普特治疗公司 2023-10-03 CN claimed
WO-2023101490-A1 NOVEL METHOD FOR MANUFACTURING GANIRELIX 애니젠 주식회사 2023-06-08 WO claimed
EP-2247577-B2 METHOD FOR THE REGIOSELECTIVE SYNTHESIS OF 1-ALKYL-3-HALOALKYL-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES BAYER IP GMBH (DE) 2022-04-27 EP claimed
US-20260150488-A1 INDACENE AND AZAINDACENE COMPOUNDS AND HIGHER HOMOLOGUES AND THE USE THEREOF Credoxys GmbH (DE) 2026-05-28 US disclosed
US-20260124177-A1 CO-THERAPIES INCLUDING A METASTASIS INHIBITOR NOVITA PHARMACEUTICALS, INC. (US) 2026-05-07 US disclosed
US-20260103447-A1 METHODS FOR PREPARING PSMA CONJUGATES ENDOCYTE, INC. 2026-04-16 US disclosed
EP-4096662-B1 PROCESS FOR PREPARATION OF LASMIDITAN ALIVUS LIFE SCIENCES LTD (IN) 2026-03-25 EP disclosed
US-12577236-B2 Processes for preparation of Tezacaftor LAURUS LABS LIMITED (IN) 2026-03-17 US disclosed
US-12508245-B2 Co-therapies including a metastasis inhibitor NOVITA PHARMACEUTICALS, INC. (US) 2025-12-30 US disclosed
US-20250368657-A1 METHODS FOR INHIBITING FASCIN NOVITA PHARMACEUTICALS INC (US) 2025-12-04 US disclosed
US-12473265-B2 Methods for preparing PSMA conjugates ENDOCYTE, INC. (US) 2025-11-18 US disclosed
EP-2665119-A1 METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND APPLICATION THEREOF Showa Denko K.K. (JP) 2013-11-20 EP disclosed
US-20130295483-A1 METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND USES THEREOF SHOWA DENKO K.K. (JP) 2013-11-07 US disclosed
US-20130288154-A1 METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND USES THEREOF SHOWA DENKO K.K. (JP) 2013-10-31 US disclosed
US-20130150340-A1 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors SANOFI (FR) 2013-06-13 US disclosed
WO-2013045413-A1 6-(4-HYDROXY-PHENYL)-3-ALKYL-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS SANOFI (FR) 2013-04-04 WO disclosed
US-7986510-B1 Carbon electrodes and electrochemical capacitors SMITH, W. NOVIS 2011-07-26 US disclosed
CN-100554256-C Quaternary ammonium salt, electrolyte and electrochemical device OTSUKA CHEMICAL CO LTD (JP) 2009-10-28 CN disclosed
CN-1802362-A Quaternary ammonium salt, electrolyte and electrochemical device OTSUKA CHEMICAL CO LTD (JP) 2006-07-12 CN disclosed